Aurobindo Pharma reported INR575.38M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Cipla INR 807.87M 88K Sep/2026
Divis Laboratories Ltd INR 265.47M 0 Sep/2026
Dr.Reddys Laboratories INR 833.07M 382K Sep/2026
Hindustan Unilever INR 2.35B 0 Sep/2026
Sun Pharmaceuticals INR 2.4B 0 Sep/2026
UPL INR 844.17M 0 Sep/2026